AzTrials
AzTrials

HealthyNCT03743363

Effects of Exergaming Session Frequency on Work Performance, Cognition, and Mobility in Adults Age 55 to 65

A study testing Exergame 2/week and Exergaming 3/week in people with Healthy, run by Somogy Megyei Kaposi Mór Teaching Hospital at 1 site in Hungary.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim - determine the immediate and lasting effects of Exergaming frequency on work performance, health, motor, and cognitive function in clerical employees. Read more about this study

Who is it for?
Ages 55 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Exergame 2/week and Exergaming 3/week
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteHungary
Study dates
15 Nov 2018to 1 Feb 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age
  • active worker
  • no detected neurological status

Who cannot join

  • Sever heart problem
  • Sever demeanor
  • Alkoholism
  • Drug problems

Trial locations and contacts

1 site in 1 country.

Hungary1 site
  • Somogy Megyei Kaposi Mór Oktató Kórház

    Kaposvár, Somogy County, 7400

Other trials in Hungary

About this study

Aim - determine the immediate and lasting effects of Exergaming frequency on work performance, health, motor, and cognitive function in clerical employees.

Read the detailed description

Hypothesis - In sedentary clerical workers the introduction of even 1 session / week exercise can cause lasting and correlated improvements in work, motor, and cognitive function, and effect which plateaus at 2 compared with 3 sessions / week. However, 6 months follow up would show residual effects only at the 3/week frequency in those who had become sedentary again.

Conditions
Healthy
Being tested
Exergame 2/week, Exergaming 3/week, Healthy control / Exergaming 1/week
Keywords
balance, movement, exergaming, work performance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exergame 2/weekOther

    virtual training 2 times a week(8 week-long)

  • Exergaming 3/weekOther

    virtual training 3 times a week(8 week-long)

  • Healthy control / Exergaming 1/weekOther

    In the first 8 week-long only control group. For the next 8 weeks, the control group will do 1 workout per week.

Study groups in NCT03743363
Study groupRoleWhat they receive
Exergame 3/weekExperimentalThe group does active training for 8 weeks after not training.
Receives: Other: Exergaming 3/week
Exergame 2/weekExperimentalThe group does active training for 8 weeks after not training.
Receives: Other: Exergame 2/week
Healthy control / Exergame 1/weekExperimentalIn the first 8 week-long only control group, The group will do 1 training/week for the next 8 weeks.
Receives: Other: Healthy control / Exergaming 1/week

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor function

    Step test (as described by Prieske et al, motion and endurance test)

    Measured: 8 weeks

  2. Motor Function

    Grip strength - Chair rise (as part of SPPB) the higher score better performance

    Measured: 8 weeks

  3. MOBILITY

    -SPPB - the higher score better performance

    Measured: 8 weeks

  4. BALANCE Functional reach

    Beam walking (4, 8, 12 cm 3 trials each, summed distance score) The longer the journey is, the better the performance

    Measured: 8 weeks

  5. Cognitive function

    • MMSE (questionnaire…) the higher score better performance

    Measured: 8 weeks

  6. Cognitive function

    • Processing speed: The Digit Symbol Substitution Test (DSST)

    Measured: 8 weeks

  7. Mobility

    6MWT - The longer the journey is, the better the performance

    Measured: 8 weeks

  8. Mobility

    Fast gait speed over 10 m - speed, the faster the better

    Measured: 8 weeks

  9. Cognitive function

    Verbal and visual memory span and working memory (0-100 visual analog sclae-the higher score better performance)

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2018
  2. Study start15 Nov 2018
  3. Primary completion15 Jan 2019
  4. Study completion1 Feb 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03743363
Sponsor's protocol ID
IKEB009/2018
Status last verified
Nov 2018
First submitted
6 Nov 2018
Last updated
28 Apr 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hortobagyi T, Deak D, Farkas D, Blenyesi E, Torok K, Granacher U, Tollar J. Effects of Exercise Dose and Detraining Duration on Mobility at Late Midlife: A Randomized Clinical Trial. Gerontology. 2021;67(4):403-414. doi: 10.1159/000513505. Epub 2021 Mar 3.

    PubMed 33657562

Questions about this trial

What is this clinical trial studying?

A study testing Exergame 2/week and Exergaming 3/week in people with Healthy, run by Somogy Megyei Kaposi Mór Teaching Hospital at 1 site in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor function (time frame: 8 weeks). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03743363, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03743363 | AzTrials